 | | | | Spain's government said on Thursday a U.S. proposal to waive patents on coronavirus vaccines signals the "way forward" but will not be enough to guarantee supplies to developing countries. | | | | | | Drugmakers on Thursday said U.S. President Joe Biden's support for waiving patents of COVID-19 vaccines could disrupt a fragile supply chain and that rich countries should instead share more generously with the developing world. | | | | | | Pfizer Inc (PFE.N) and its German partner BioNTech SE said on Thursday they would donate doses of their COVID-19 vaccine to help vaccinate athletes and their delegations participating in the Tokyo Olympic and Paralympic Games. | | | | | | The COVID-19 pandemic has caused nearly 6.9 million deaths across the world, more than double the number officially recorded, a new analysis from the University of Washington's Institute for Health Metrics and Evaluation (IHME) estimated. | | | | | | Police in Catalonia were preparing for hordes of pandemic-weary revellers to hit the streets when a national state of emergency expires on Sunday, while regional leaders across Spain vented frustration at uncertainty over what comes next. | | | | | | The governors of two more U.S. states said on Thursday they were lifting most restrictions that were put in place to combat the spread of the coronavirus after sharp drops in infection rates and deaths. | | | | | | Hopes that India's rampaging second wave of COVID-19 is peaking were set back on Thursday as record daily infections and deaths were reported and as the virus spread from cities to villages that were poorly equipped to cope. | | | | | | Canadians want vaccines. Many can't figure out how to get them. | | | | | | The European Union on Thursday backed a U.S. proposal to discuss waiving patent protections for COVID-19 vaccines, but drugmakers and some other governments opposed the idea, saying it would not solve global inoculation shortages. | | | | | | The Swiss government said on Thursday a U.S. announcement that it would support waiving intellectual property rights for COVID-19 vaccines was significant but left many questions unanswered. | | | | | |
